// App-Quantinova.ai

TCTAP A-170 : Efficacy of Everolimus-eluting Stent Implantation in Patients with Small Coronary(2.5mm) Arteries: Outcomes of 2-year Clinical Follow-up

Researchers

Presenter

  • Wataru Koguchi

Principal Investigators

  • Hideki Yano

  • Yoshimasa Shibata

  • Shigeo Horinaka

  • Mayuko Ishikawa

  • Toshihiko Ishimitsu

Medical Centers

  • Dokkyo Medical University, Mibu, Japan

  • Ashikaga Red Cross Hospital, Tochigi, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary artery lesions

  • Venous thrombosis

  • Restenosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved